http://www.pharmaceutical-technology.com/uncategorized/mrna-1010-moderna-influenzavirus-b-infections-likelihood-of-approval/
0
0
MRNA-1010 by Moderna for Influenzavirus B Infections: Likelihood of Approval - Pharmaceutical Technology
12/5/23 at 5:07am
Organization
Pharmaceutical Technology
Author
kgi-admin
30 words
0
Comments
MRNA-1010 is under clinical development by Moderna and currently in Phase III for Influenzavirus B Infections.
You are the first to view
Create an account or login to join the discussion